Cairo University
Cairo, AlManial, 11562, Egypt
Location status: Recruiting
Location contact
Omar A Ashour, PHD
CONTACT
Riham O Professor, PHD
CONTACT
NCT Number: NCT07526259
Defects associated with severe interdental hard and soft tissue loss are challenging to the periodontist, mainly due to the increased avascular surface and the reduced interproximal periosteal bed. Reports on the surgical techniques used to address recession type 2 or 3 defects mostly showed statistics on the mid-facial root coverage that yielded outcomes that do not encompass coverage of the interdental exposed root surface which highlights areas of controversy in their use for papilla reconstruction. Several case reports and clinical studies have shown encouraging results, but the long-term data are not available in the literature yet. The novel 3D tunneling (3DT) method achieved significant clinical improvement with long term stability in a recent case series. However, additional research is needed to validate 3DT for its routine clinical use. Moreover, the 3DT method achieved a decrease in the lingual recession depth which should be pointed out that the technique also addresses lingual recession.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Cairo, AlManial, 11562, Egypt
Location status: Recruiting
Omar A Ashour, PHD
CONTACT
Riham O Professor, PHD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The novel 3D tunneling (3DT) method achieved significant clinical improvement with long term stability in a recent case series. However, additional research is needed to validate 3DT for its routine clinical use.
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
Time frame: From enrollment to the end of treatment at 1 year
The RES system evaluates five variables 1 year following surgery: GM, marginal tissue contour (MTC), soft tissue texture (STT), MGJ alignment, and gingival color (GC).
GM. Zero points = failure of root coverage (gingival margin apical or equal to the baseline recession); 3 points = partial root coverage; 6 points = CRC.
MTC. Zero points = irregular gingival margin (does not follow the CEJ); 1 point = proper marginal contour/scalloped gingival margin (follows the CEJ).
STT. Zero points = scar formation and/or keloid-like appearance; 1 point = absence of scar or keloid formation.
MGJ. Zero points = MGJ not aligned with the MGJ of adjacent teeth; 1 point = MGJ aligned with the MGJ of adjacent teeth.
GC. Zero points = color of tissue varies from gingival color at adjacent teeth; 1 point = normal color and integration with the adjacent soft tissues.
Thus, the ideal esthetic score is 10.
Time frame: From enrollment to the end of treatment at 1 year
Pain score will be reported by the patient directly through Visual Analogue Scale (VAS) score (between 0 and 10.0: no pain, 1: minimal pain, 5: moderate pain, 10: severe pain) will be recorded at day 3, day 7, and day 14.
Cairo University
Other
Comparative Evaluation of Novel 3D Tunneling Technique Versus Modified Coronally Advanced Tunnel (MCAT) With Connective Tissue Graft in the Management of Multiple RT2 Gingival Recession: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04920136
Gingival Diseases, Gingival Recession
Birmingham, Alabama, United States
View Trial DetailsNCT07687654
Gingival Diseases, Gingival Recession
Adıyaman, Merkez, Turkey (Türkiye)
View Trial DetailsNCT05688293
Gingival Diseases, Gingival Recession
Cairo, Egypt
View Trial DetailsNCT06988839
Gingival Diseases, Gingival Recession
Rohtak, Haryana, India
View Trial Details